Basics of Targeted Drug DeliveryAddressing Unmet Medical Needs using Targeted Drug Delivery Systems: Emphasis on Nanomedicine-Based ApplicationsNanocarriers Based Targeted Drug Delivery Systems: Small and MacromoleculesLiposomes as Targeted Drug Delivery SystemsAntibody-Drug Conjugates: Development and ApplicationsGene-Directed Enzyme Prodrug Therapy (GDEPT) as a Suicide Gene Therapy Modality for Cancer TreatmentTargeted Prodrugs in Oral Drug DeliveryExosomes for Drug Delivery Applications in Cancer and Cardiac IndicationsDelivery of Nucleic Acids such as siRNA and mRNA using Complex FormulationsApplication of PROTAC Technology in Drug DevelopmentMetal Complexes as the Means or the End of Targeted Delivery for Unmet NeedsFormulation of Peptides for Targeted DeliveryAntibody-Based Targeted T Cell TherapiesDevices for Active Targeted Delivery: A Way to Control the Rate and Extent of Drug AdministrationDrug Delivery to the Brain: Targeting Technologies to Delivery Therapeutics to Brain Lesions
Yogeshwar Bachhav is a pharmacist by training and holds a PhD in drug delivery systems from ICT, Mumbai (India). He has worked as research scientist for several years on a collaborative project between Pantec Biosolutions and Geneva University (Switzerland), and as formulation manager at Debiopharm Group, Lausanne (Switzerland). For the last 5 years he has been working as Associate Director at AiCuris Anti-infective Cures GmbH, Germany and has been responsible for pharmaceutical development. In total, he has around 14 years of experience in the preformulation and formulation development of small molecules and/or peptides for oral, dermal and parenteral application. He has more than 16 international publications, 6 European patents and over 30 conference proceedings to his credit. He has recently edited a book for Wiley-VCH: Innovative Dosage Forms: Design and Development at Early Stage.